Phase II clinical trial of gemcitabine and Doxil [doxorubicin liposomal] for metastatic renal cell carcinoma
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Gemcitabine (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 01 Apr 2011 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 01 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.